The market currently undervalues Chimera's common stock by an enormous margin, trading it at price-to-book ratios that are far below its peers. The Company’s track record is strong, showing positive ...
Chimera has consistently experienced substantial capital destruction, losing over 90% of its value since 2009 despite various market conditions. The allure of the company's high dividend yield, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results